Jack Perry Antel
Impact in
- Pathology and Forensic Medicine top 0.01%
- Multiple Sclerosis Research Studies
- Neurology top 0.01%
- Neuroinflammation and Neurodegeneration Mechanisms
- Amyotrophic Lateral Sclerosis Research
Papers in
-
- Multiple Sclerosis Research Studies 244
- Neurology 74
- Neuroinflammation and Neurodegeneration Mechanisms 65
- Amyotrophic Lateral Sclerosis Research 19
- Barrier Structure and Function Studies 9
- Co-authors
- Amit Bar‐Or (66 shared papers)Douglas Lorne Arnold (31 shared papers)Alexandre Prat (51 shared papers)Tanja Kuhlmann (26 shared papers)Burkhard Becher (25 shared papers)Paul McMahan Matthews (14 shared papers)Wolfgang Brück (14 shared papers)Voon Wee Yong (25 shared papers)
- Journals
- Journal of Neuroimmunology (47 papers)Annals of Neurology (40 papers)Neurology (38 papers)Glia (27 papers)The Journal of Immunology (22 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Jack Perry Antel
530 papers receiving 46.3k citations
Jack Perry Antel's Hit Papers
Peers
Comparison fields: 5 of 124
- Pathology and Forensic Medicine 17.6k
- Neurology 5.6k
- Developmental Neuroscience 1.1k
- Biological Psychiatry 269
- Neurology 2.1k
Countries citing papers authored by Jack Perry Antel
This map shows the geographic impact of Jack Perry Antel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Perry Antel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Perry Antel more than expected).
Fields of papers citing papers by Jack Perry Antel
This network shows the impact of papers produced by Jack Perry Antel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Perry Antel. The network helps show where Jack Perry Antel may publish in the future.
Co-authors
The 25 scholars most cited alongside Jack Perry Antel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 536 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification of a unique TGF-β–dependent molecular and functional signature in microglia Hit paper breakdown → | 2013 | 2087 |
| 2 | B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis Hit paper breakdown → | 2008 | 2021 |
| 3 | Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor Hit paper breakdown → | 2016 | 1284 |
| 4 | Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis Hit paper breakdown → | 2006 | 914 |
| 5 | Microglial control of astrocytes in response to microbial metabolites Hit paper breakdown → | 2018 | 874 |
| 6 | iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases Hit paper breakdown → | 2017 | 868 |
| 7 | Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial Hit paper breakdown → | 2009 | 779 |
| 8 | Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Hit paper breakdown → | 2018 | 747 |
| 9 | Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand Hit paper breakdown → | 2000 | 725 |
| 10 | Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis Hit paper breakdown → | 2008 | 697 |
| 11 | Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neurons Hit paper breakdown → | 1992 | 654 |
| 12 | 2005 | 610 | |
| 13 | An updated histological classification system for multiple sclerosis lesions Hit paper breakdown → | 2016 | 536 |
| 14 | Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica Hit paper breakdown → | 2009 | 511 |
| 15 | 2000 | 457 | |
| 16 | 2019 | 447 | |
| 17 | 2017 | 431 | |
| 18 | 2001 | 425 | |
| 19 | Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation Hit paper breakdown → | 2014 | 415 |
| 20 | 2012 | 408 |
About Jack Perry Antel
Jack Perry Antel is a scholar working on Pathology and Forensic Medicine, Neurology, Developmental Neuroscience, Immunology and Neurology, having authored 536 papers that have together received 47.9k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (244 papers), Neuroinflammation and Neurodegeneration Mechanisms (65 papers), Neurogenesis and neuroplasticity mechanisms (27 papers), T-cell and B-cell Immunology (20 papers), Amyotrophic Lateral Sclerosis Research (19 papers), Barrier Structure and Function Studies (9 papers), Sphingolipid Metabolism and Signaling (9 papers) and Glioma Diagnosis and Treatment (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (17.6k citations), Neurology (5.6k citations), Developmental Neuroscience (1.1k citations), Biological Psychiatry (269 citations) and Neurology (2.1k citations). Jack Perry Antel has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Amit Bar‐Or, Douglas Lorne Arnold, Alexandre Prat, Tanja Kuhlmann, Burkhard Becher, Paul McMahan Matthews, Wolfgang Brück, Voon Wee Yong, Craig Stephen Moore and Véronique E. Miron. Their work appears in journals such as Journal of Neuroimmunology, Annals of Neurology, Neurology, Glia and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.